Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial

Andrew R. Clamp, Jonathan A. Ledermann, Dolores Gallardo‐Rincón et al.|The Lancet Oncology|2022

Cited by 45